Task Force Links Biphosphonates To Rare Bone Breaks

Law360, New York (September 14, 2010, 6:10 PM EDT) -- A class of drugs widely prescribed for reducing bone fractures in osteoporosis patients may also be connected to a type of rare thigh bone fracture, a top bone science organization said in a report released Tuesday.

A task force convened by the American Society of Bone and Mineral Research said it had reviewed more than 300 cases of these atypical femur fractures and found that more than 90 percent of the patients suffering from the breaks had taken biphosphonates, most for more than five years....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.